Tag: pharmaceutical industry

“Americans suffering from chronic health problems and pain conditions should not have to be concerned about collusion by pharmaceutical executives that could increase the price of their essential medications.”

Trump’s top healthcare adviser, former Gilead Sciences lobbyist Joe Grogan, strenuously lobbied within the White House and on Capitol Hill against price negotiations.

Amid an onslaught of lawsuits, Johnson & Johnson has kept pace with its historically hefty lobbying efforts as it wrestles to maintain influence in the halls of Congress.

In her new explosive book “Bottle of Lies: The Inside Story of the Generic Drug Boom,” investigative journalist Katherine Eban works with two industry whistleblowers to expose how some manufacturers are cutting corners at the cost of quality and safety.

"Because every single developed country in the world guarantees healthcare as a right except us. Except the United States."

Any "congressional staffer serious about finding solutions wouldn't touch that retreat with a 10-foot pole."

"Teva and its co-conspirators embarked on one of the most egregious and damaging price-fixing conspiracies in the history of the United States."

The powerful corporate and government forces that minimize the less powerful must be challenged, even in the face of overwhelming odds.

This month, more than 300 doctors and medical researchers sent an open letter to the Centers for Disease Control and Prevention warning patients have been harmed by a lack of clarity in guidelines for prescribing opioids.

Purdue is considering bankruptcy to halt thousands of lawsuits and allow the company to settle with the plaintiffs out of court.